CORDANI, NICOLETTA
 Distribuzione geografica
Continente #
NA - Nord America 2.238
EU - Europa 1.163
AS - Asia 295
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 3.702
Nazione #
US - Stati Uniti d'America 2.196
IT - Italia 408
IE - Irlanda 195
DE - Germania 157
SE - Svezia 157
CN - Cina 143
UA - Ucraina 83
HK - Hong Kong 66
GB - Regno Unito 55
CA - Canada 41
IN - India 33
FI - Finlandia 28
FR - Francia 20
SG - Singapore 19
DK - Danimarca 14
VN - Vietnam 14
NL - Olanda 12
TR - Turchia 12
BE - Belgio 10
PL - Polonia 5
EU - Europa 4
JP - Giappone 4
RU - Federazione Russa 4
BG - Bulgaria 3
MT - Malta 3
BR - Brasile 2
ES - Italia 2
KR - Corea 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
GR - Grecia 1
ID - Indonesia 1
PR - Porto Rico 1
UZ - Uzbekistan 1
Totale 3.702
Città #
Ann Arbor 574
Woodbridge 219
Chandler 203
Dublin 189
Milan 173
Fairfield 168
Houston 141
Frankfurt am Main 123
Wilmington 108
Ashburn 95
Jacksonville 92
New York 85
Seattle 74
Dearborn 69
Hong Kong 65
Cambridge 62
Princeton 38
Nanjing 37
Lissone 27
Shanghai 24
Rome 21
Lawrence 17
Beijing 15
Lachine 15
Boardman 12
Carate Brianza 12
Nanchang 12
Monza 11
San Diego 11
Altamura 10
Brussels 10
Pune 10
Helsinki 8
Ottawa 8
Tianjin 8
Andover 7
Hebei 7
Los Angeles 7
Shenyang 7
Toronto 7
Lecco 6
Cinisello Balsamo 5
Dong Ket 5
Edmonton 5
Falls Church 5
Fremont 5
Hangzhou 5
Lodz 5
London 5
Norwalk 5
Auburn Hills 4
Gallarate 4
Genoa 4
Huizen 4
Jiaxing 4
Lappeenranta 4
Montréal 4
Palermo 4
Zhengzhou 4
Ardea 3
Changchun 3
Changsha 3
Desio 3
Hyderabad 3
Jinan 3
Marano di Napoli 3
Marino 3
Melita 3
Padova 3
Washington 3
Bratislava 2
Bursa 2
Ciampino 2
Daejeon 2
Garbagnate Milanese 2
Gerenzago 2
Inzago 2
Kilburn 2
Kocaeli 2
Lambesc 2
Lanzhou 2
Maarssen 2
Minturno 2
Monterotondo 2
Mumbai 2
Naples 2
Nerviano 2
Perugia 2
Plovdiv 2
Pordenone 2
Quart de Poblet 2
Salerno 2
San Severo 2
Sesto San Giovanni 2
Sint Odilienberg 2
Southwark 2
Tokyo 2
Tradate 2
Woerden 2
Acton 1
Totale 2.960
Nome #
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 340
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 267
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 258
Chronic myeloid leukemia: Second-line drugs of choice 256
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 237
Expression of heat shock protein 27 in human renal cell carcinoma 208
Isolation of FAP Cells from Mouse Dystrophic Skeletal Muscle Using Fluorescence Activated Cell Sorting 181
Mutant p53 subverts p63 control over KLF4 expression in keratinocytes 177
Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma 162
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues 147
Comparative proteomics of membrane microdomains from renal cell carcinoma and adiacent normal kidney 143
Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts 142
Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases 141
Nitric Oxide Controls Fat Deposition in Dystrophic Skeletal Muscle by Regulating Fibro-Adipogenic Precursor Differentiation 137
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 134
The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFN alpha on pleomorphic sarcoma cells 110
Derangement of endothelial protein C receptor and thrombomodulin expression in the intestinal mucosa of patients with inflammatory bowel diseases 105
EGFR overexpression in malignant pleural mesothelioma: An immunohistochemical and molecular study with clinico-pathological correlations 95
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease 93
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 90
Investigation of the origin of malignant fibrous histiocytoma and identification of specific predictive markers for this tumour 85
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 61
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 46
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 37
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective 29
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows 28
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons 28
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer 27
Metronomic chemotherapy 27
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study 25
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 20
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story 18
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 15
Edaravone: A Novel Possible Drug for Cancer Treatment? 7
Totale 3.876
Categoria #
all - tutte 11.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.590


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019132 0 0 0 0 0 0 0 0 0 0 50 82
2019/2020670 79 54 49 53 62 75 90 49 64 41 43 11
2020/2021593 26 26 63 68 62 61 58 41 44 55 36 53
2021/2022293 30 42 48 32 8 21 13 15 11 19 21 33
2022/2023763 48 200 39 91 46 72 43 40 36 64 48 36
2023/2024776 50 50 32 51 115 187 146 40 53 39 13 0
Totale 3.876